AstraZeneca has secured approval from the US Food and Drug Administration (FDA) for its Farxiga (dapagliflozin) to reduce the risk of hospitalisation …
“In the UAE, 30 per cent of respondents are battling HBP, a possible precursor to heart disease, yet close to half of them do not perceive this as fatal,” …
Atrial fibrillation is the most common heart rhythm disorder and increases the risk of stroke by up to five-fold. Symptoms include palpitations, racing or …
The rising rate of heart disease in the Northern Territory is “taking too many lives” at a higher rate than anywhere else in Australia, the Top End’s Heart …